|
|
THE TOP NEWS IN MARIJUANA LAW REFORM
Volume 25 • Issue 19 • May 12, 2022
|
|
|
|
|
Thirty-nine percent of patients were able to either "completely discontinue [their use of] insomnia medications or reduce their use from nightly administration to as-needed administration."
|
|
|
|
|
|
|
|
Investigators concluded, "[P]atients who seek treatment with medical cannabis for anxiety and depression can experience clinically significant improvements."
|
|
|
|
Legalization Advocates in Missouri, South Dakota Turn in Signatures for November Ballot ... Details
05/10/22 2:30pm UTC
Texas: Austin Voters Decide in Favor of Municipal Ballot Initiative Eliminating Local Cannabis Penalties Details
05/09/22 6:18pm UTC
State Policy Weekly Update 5/6/2022 Details
05/06/22 3:17pm UTC
|
|
|
|
|
|
|
|
Authors reported, "[P]eople with PD report that cannabis subjectively improves some PD-related symptoms, with higher THC products conferring more frequent benefits than higher CBD products."
|
|
|
|
|
|
The analysis found that nearly two-thirds of the products contained synthetically derived THC, despite many claiming to be 'all natural.'
|
|
|
|
|
|
|
|
Sent via ActionNetwork.org.
To update your email address, change your name or address, or to stop receiving emails from NORML, please click here.
|
|
|
|
